MARKET SNAPSHOT: Dow, S&P 500 On Track For Records, But Health-care Slumps On Trump
07 Dezembro 2016 - 1:33PM
Dow Jones News
By Mark DeCambre and Victor Reklaitis, MarketWatch
The IBB is on track for its worst daily drop since October
The Dow industrials and S&P 500 on Wednesday opened slightly
lower, but were trading within striking distance of records ahead
of a key meetings by European and U.S. central banks that has kept
investors on a cautious footing.
A rapid advance in stock-market indexes since the Nov. 8
presidential election fueled a euphoric rally has raised some
concerns that equity values have become overextended. A tumble in
shares of health-care companies after comments from the
president-elect and a second decline in crude-oil prices also kept
the market in check.
The Dow Jones Industrial Average was trading 16 points, or 0.1%,
higher at 19,266, ahead of its all-time closing high set Tuesday. A
1% rise in shares of Goldman Sachs Group(GS) helped to support the
blue-chip benchmark, while a slump in health-care shares of Johnson
& Johnson(JNJ) Pfizer Inc.(PFE), and Merck & Co. Inc.(MRK),
slumped after President-elect Donald Trump threatened to cut drug
prices
(http://www.marketwatch.com/story/president-elect-trumps-promise-to-bring-down-drug-prices-sends-biotech-etfs-slumping-2016-12-07).
"I'm going to bring down drug prices," Trump told Time in his
"Person of the Year" cover story
(http://time.com/time-person-of-the-year-2016-donald-trump/). "I
don't like what has happened with drug prices."
The iShares Nasdaq Biotechnology ETF(IBB), the most widely used
way to place bets on the health-care and biotech space, sank 3.3%,
and was on track for its worst daily decline since Oct. 11,
according to FactSet data.
The IBB's drop weighed on the Nasdaq Composite Index which was
the worst performer among the three main benchmarks, down 0.4% at
5,312.
The S&P 500 index added a point, or less than 0.1%, at
2,213, with all but one of the S&P 500's 11 sector in positive
territory. Health-care led the way lower, with a 1.8%, decline.
On Tuesday, the S&P 500 finished 0.3% higher, within 0.1% of
its Nov. 25 record close of 2,213.35. The Dow gained 0.2% and
finished at an all-time high for a second straight session
(http://www.marketwatch.com/story/dow-reaches-for-a-fresh-record-but-itll-be-a-struggle-2016-12-06).
The Nasdaq Composite added 0.5%.
The stock market's postelection climb has been underpinned by
hopes that Trump will follow through with a slate of pro-business
policies, including boosting infrastructure spending and cutting
taxes for the wealthy.
However, some strategists and traders are concerned that a
pullback
(http://www.marketwatch.com/story/gundlach-says-the-trump-trade-is-losing-steam-2016-12-02)
might be in the offing.
"It appears that nothing can stop the equity rally," said Naeem
Aslam, chief market analyst at ThinkMarkets UK, in a note.
"If you look at the volatility index, it has dropped near the 11
handle, which confirms that appetite for riskier assets is strong,"
he added, referring to the CBOE Volatility Index . "Buying
volatility at these levels may not be that much of a bad idea."
Read:Why the rally by U.S. stocks is 'just getting started'--in
one chart
(http://www.marketwatch.com/story/why-the-rally-by-us-stocks-is-just-getting-started-in-one-chart-2016-11-28)
Other markets:European stocks
(http://www.marketwatch.com/story/credit-suisse-miners-push-stoxx-europe-600-toward-highest-close-since-september-2016-12-07)
gained, with banks and miners among the session's big winners, and
Asian markets closed broadly higher
(http://www.marketwatch.com/story/bank-stocks-surge-as-asian-markets-post-gains-2016-12-06).
Oil futures
(http://www.marketwatch.com/story/oil-prices-continue-to-backtrack-as-investors-question-opec-deal-2016-12-07)
retreated, while gold futures and a key dollar index
(http://www.marketwatch.com/story/dollar-flattens-out-as-investors-look-ahead-to-fed-ecb-meetings-2016-12-07)
were modestly higher.
Individual stocks: Ahead of the opening bell, Brown-Forman
Corp.(BFA) reported quarterly sales that topped estimates
(http://www.marketwatch.com/story/brown-forman-sales-top-estimates-sticks-with-full-year-view-2016-12-07),
as the maker of Jack Daniel's whiskey backed its full-year
forecast. The stock wasn't yet active in premarket trade.
Handbag seller Vera Bradley Inc.(VRA) cut its full-year outlook
(http://www.marketwatch.com/story/vera-bradley-shares-slump-as-company-cuts-outlook-2016-12-07)
after missing its own guidance range for the third quarter. Shares
were tumbling 11% in early trade.
Economic news: A report on consumer credit is due at 3 p.m.
Eastern.
The JOLTS report, or Job Openings and Labor Turnover Survey,
showed that job openings were unchanged at 5.5 million in October,
according to Labor Department.
Investors also are bracing for the European Central Bank's
policy-setting meeting
(http://www.marketwatch.com/story/how-italys-no-vote-might-be-the-ecbs-silver-lining-2016-12-05)
on Thursday. The Federal Reserve entered the so-called blackout
period Tuesday ahead of its meeting Dec. 13-14, so there are no Fed
speakers on the docket.
Check out:
(END) Dow Jones Newswires
December 07, 2016 10:18 ET (15:18 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
iShares Biotechnology ETF (NASDAQ:IBB)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
iShares Biotechnology ETF (NASDAQ:IBB)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024